-
Product Insights
NewTranscatheter Mitral Valve Implantation (TMVI) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Market Report Overview The transcatheter heart valve is an artificial heart valve made up of natural tissue surrounded by a flexible mesh frame known as stent. All the components are placed in a long narrow tube known as a catheter which is then inserted into a large blood vessel in the groin area or through a small incision in chest. The transcatheter mitral valve implantation (TMVI) pipeline market research report provides a comprehensive understanding...
-
Product Insights
Aneurysm – Drugs In Development, 2023
Global Markets Direct’s, ‘Aneurysm - Drugs In Development, 2023’, provides an overview of the Aneurysm pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aneurysm, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Atherosclerosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Atherosclerosis - Drugs In Development, 2023’, provides an overview of the Atherosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atherosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Arteriosclerosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Arteriosclerosis - Drugs In Development, 2023’, provides an overview of the Arteriosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arteriosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Metrovacesa – Tiara Residential Complex – Andalusia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Metrovacesa - Tiara Residential Complex - Andalusia report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? ·Unleash the full story: Dive deep into...
-
Company Profile
Neovasc Inc – Company Profile
Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include neovasc reducer, neovasc tiara, and neovasc tissue products. Its neovasc tiara is a novel transcatheter device that is designed for treating mitral valve disease and mitral regurgitation and a condition that is often severe and can lead to heart failure and death. Neovasc reducer is used for treating refractory angina. The company’s reducer procedure uses standard catheter-based techniques. It...
Add to Basket -
Product Insights
Neovasc Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Neovasc Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is designed for treating mitral valve disease and mitral regurgitation and a condition that is often severe and can lead to heart...
-
Product Insights
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Atherosclerosis (or arteriosclerotic vascular disease) may occur with symptoms including chest pain (angina), pain in the leg, arm, and anywhere else that an artery is blocked, shortness of breath, fatigue, confusion (if the blockage affects circulation to the brain) and muscle weakness in the legs from lack of circulation. The Atherosclerosis pipeline drugs market research report outlays comprehensive information on the Atherosclerosis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA)...